摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-Dimethylphenyl carbamate

中文名称
——
中文别名
——
英文名称
3,5-Dimethylphenyl carbamate
英文别名
(3,5-dimethylphenyl) carbamate
3,5-Dimethylphenyl carbamate化学式
CAS
——
化学式
C9H11NO2
mdl
——
分子量
165.19
InChiKey
SBTVLCPCSXMWIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Enantioselective separation method
    申请人:Chekal P. Brian
    公开号:US20060020022A1
    公开(公告)日:2006-01-26
    This invention relates to a method for separating enantiomers of a substituted 2-trifluoromethyl-2H-chromene-3-carboxylic acid or ester, a substituted 2-trifluoromethyl-1,2-dihydro-quinoline-3-carboxylic acid or ester, a substituted 2-trifluoromethyl-2H-thiochromene-3-carboxylic acid or ester, a substituted 3-trifluoromethyl-3,4-dihydro-naphthalene-2-carboxylic acid or ester, or a pharmaceutically acceptable salt of the acids or esters, using enantioselective fractional crystallization, enantioselective high performance liquid chromatography, enantioselective steady state recycling chromatography, or enantioselective multicolumn chromatography.
    本发明涉及一种分离取代的2-三氟甲基-2H-色烯-3-羧酸或酯、取代的2-三氟甲基-1,2-二氢喹啉-3-羧酸或酯、取代的2-三氟甲基-2H-硫色烯-3-羧酸或酯、取代的3-三氟甲基-3,4-二氢萘-2-羧酸或酯、或药物可接受的盐的对映体分离方法,使用对映选择性分数结晶、对映选择性高效液相色谱、对映选择性稳态循环色谱或对映选择性多柱色谱。
  • METHOD FOR THE PREPARATION OF ESCITALOPRAM
    申请人:Sommer Michael B.
    公开号:US20110065938A1
    公开(公告)日:2011-03-17
    A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as Chiralpak™ AD or Chiralcel™ OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided.
    提供了一种制造艾司西酞普兰的新方法。该方法包括使用手性固定相,如Chiralpak™ AD或Chiralcel™ OD,对西酞普兰的对映体或制备西酞普兰的中间体进行色谱分离。还提供了由该方法制造的用于合成艾司西酞普兰的新手性中间体。
  • Method for the preparation of escitalopram
    申请人:Sommer B Michael
    公开号:US20050065207A1
    公开(公告)日:2005-03-24
    A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as Chiralpak™ or Chiralcel™ OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided.
    提供了一种制造艾司西酞普兰的新方法。该方法包括使用手性固定相(如Chiralpak™或Chiralcel™ OD)对西酞普兰的对映体或生产西酞普兰的中间体进行色谱分离。此外,还提供了通过该方法制造艾司西酞普兰的新手性中间体。
  • [EN] METHOD FOR THE PREPARATION OF ESCITALOPRAM<br/>[FR] PROCEDE DE PREPARATION D'ESCITALOPRAM
    申请人:LUNDBECK & CO AS H
    公开号:WO2003006449A1
    公开(公告)日:2003-01-23
    A novel method is provided for the manufacture of escitalopram. The method comprises chromatographic separation of the enantiomers of citalopram or an intermediate in the production of citalopram using a chiral stationary phase such as ChiralpakTM AD or ChiralcelTM OD. Novel chiral intermediates for the synthesis of Escitalopram made by said method are also provided.
    提供了一种制造艾司西酞普兰的新方法。该方法包括使用手性固定相(如ChiralpakTM AD或ChiralcelTM OD)对西酞普兰的对映体或制备西酞普兰的中间体进行色谱分离。还提供了通过该方法制造艾司西酞普兰的新手性中间体。
  • Chloro-, hydroxy- and alkoxysilane derivatives of polysaccharides or oligosaccharides, polymerizable and cross-linkable, their synthesis and their use as sources of novel support materials
    申请人:Institut Francais du Petrole
    公开号:US20020058763A1
    公开(公告)日:2002-05-16
    There are described chloro-, hydroxy- and alkoxysilane derivatives of polysaccharides or oligosaccharides as novel compounds which are polymerizable and cross-linkable, and a method for obtaining them; novel support materials obtained from said derivatives and containing said silane derivatives of polysaccharides or oligosaccharides chemically grafted by a covalent bond with the support and polymerized and cross-linked in a three-dimensional network and a method for obtaining them; as well as the use of said material supports in separation or in preparation of enantiomers, through employment in gaseous, liquid or supercritical chromatography, by electrophoresis, electrochromatography or by percolation processes through membranes containing said support materials.
    本文描述了聚糖或寡糖的氯基、羟基和烷氧基硅烷衍生物作为新化合物,这些化合物可聚合和交联,并提供了一种获得它们的方法;从这些衍生物中获得的新型支撑材料,其中包含通过共价键与支撑物化学接枝的聚糖或寡糖的硅烷衍生物,并在三维网络中聚合和交联,并提供了一种获得它们的方法;以及在分离或制备对映体中使用该材料支撑物的方法,通过在气态、液态或超临界色谱、电泳、电色谱或通过含有该支撑材料的膜的渗透过程中使用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐